These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 29174556)
1. Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study. Guleria S; Jensen A; Kjær SK Gynecol Oncol; 2018 Jan; 148(1):86-90. PubMed ID: 29174556 [TBL] [Abstract][Full Text] [Related]
2. Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study. Gottschau M; Jensen A; Reinholdt K; Guleria S; Munk C; Mellemkjær L; Kjær SK Breast Cancer Res Treat; 2019 Nov; 178(1):199-205. PubMed ID: 31364000 [TBL] [Abstract][Full Text] [Related]
3. Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study. Hannibal CG; Frederiksen K; Vang R; Kurman RJ; Kjaer SK Int J Cancer; 2020 Aug; 147(4):990-995. PubMed ID: 31930502 [TBL] [Abstract][Full Text] [Related]
4. Risk of epithelial ovarian cancer among women with benign ovarian tumors: a follow-up study. Guleria S; Jensen A; Toender A; Kjaer SK Cancer Causes Control; 2020 Jan; 31(1):25-31. PubMed ID: 31673820 [TBL] [Abstract][Full Text] [Related]
5. Risk of endometrial cancer among women with benign ovarian tumors - A Danish nationwide cohort study. Reinholdt K; Kjaer SK; Guleria S; Frederiksen K; Mellemkjær L; Munk C; Jensen A Gynecol Oncol; 2020 May; 157(2):549-554. PubMed ID: 32139149 [TBL] [Abstract][Full Text] [Related]
6. Risk of nonovarian cancer in a nationwide-based study of nearly 5000 women with borderline ovarian tumors in Denmark. Hannibal CG; Baandrup L; Hertzum-Larsen R; Vang R; Kurman RJ; Frederiksen K; Kjaer SK Int J Cancer; 2023 Apr; 152(7):1370-1377. PubMed ID: 36366853 [TBL] [Abstract][Full Text] [Related]
7. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006. Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323 [TBL] [Abstract][Full Text] [Related]
8. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level. Baandrup L; Faber MT; Aalborg GL; Kjaer SK Acta Obstet Gynecol Scand; 2021 Mar; 100(3):436-443. PubMed ID: 33010027 [TBL] [Abstract][Full Text] [Related]
9. Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study. Rasmussen CB; Jensen A; Albieri V; Andersen KK; Kjaer SK Gynecol Oncol; 2016 Nov; 143(2):346-351. PubMed ID: 27549433 [TBL] [Abstract][Full Text] [Related]
10. Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden. Dobilas A; Jansåker F; Li X; Sundquist K; Borgfeldt C BMC Cancer; 2023 Oct; 23(1):951. PubMed ID: 37807065 [TBL] [Abstract][Full Text] [Related]
11. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study. Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453 [TBL] [Abstract][Full Text] [Related]
12. A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma. Hannibal CG; Vang R; Junge J; Frederiksen K; Kurman RJ; Kjaer SK Gynecol Oncol; 2017 Jan; 144(1):174-180. PubMed ID: 27836204 [TBL] [Abstract][Full Text] [Related]
13. Risk of borderline ovarian tumors after fertility treatment - Results from a Danish cohort of infertile women. Kristensen AK; Frandsen CLB; Nøhr B; Viuff JH; Hargreave M; Frederiksen K; Kjær SK; Jensen A Gynecol Oncol; 2024 Jun; 185():108-115. PubMed ID: 38382167 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum? Jordan SJ; Green AC; Whiteman DC; Webb PM; Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378 [TBL] [Abstract][Full Text] [Related]
15. Second neoplasms after invasive and borderline ovarian cancer. Levi F; Randimbison L; Blanc-Moya R; La Vecchia C Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608 [TBL] [Abstract][Full Text] [Related]
16. Increased risk of second cancer among patients with ovarian borderline tumors. Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966 [TBL] [Abstract][Full Text] [Related]
17. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study. Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610 [TBL] [Abstract][Full Text] [Related]
18. Endometriosis and risks for ovarian, endometrial and breast cancers: A nationwide cohort study. Mogensen JB; Kjær SK; Mellemkjær L; Jensen A Gynecol Oncol; 2016 Oct; 143(1):87-92. PubMed ID: 27430396 [TBL] [Abstract][Full Text] [Related]
19. Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube. Soini T; Hurskainen R; Grénman S; Mäenpää J; Paavonen J; Pukkala E Acta Oncol; 2016 Nov; 55(11):1281-1284. PubMed ID: 27148621 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for benign serous and mucinous epithelial ovarian tumors. Jordan SJ; Green AC; Whiteman DC; Webb PM Obstet Gynecol; 2007 Mar; 109(3):647-54. PubMed ID: 17329516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]